News
SNN
24.50
+0.25%
0.06
Weekly Report: what happened at SNN last week (1216-1220)?
Weekly Report · 3d ago
Smith & Nephew CFO Purchases Significant Shares, Boosting Investor Confidence
TipRanks · 6d ago
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
NASDAQ · 6d ago
Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
Barchart · 12/19 09:00
SNN Stock Might Rise Following FDA Nod for AETOS Stemless
NASDAQ · 12/17 12:43
Smith & Nephew’s Shareholding Shift: BlackRock’s Increased Stake
TipRanks · 12/16 16:27
Smith & Nephew receives 510(k) clearance for AETOS Stemless
TipRanks · 12/16 15:05
Weekly Report: what happened at SNN last week (1209-1213)?
Weekly Report · 12/16 09:04
Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty
Barchart · 12/16 09:00
Smith & Nephew Announces Change in Major Holdings
TipRanks · 12/12 12:27
Smith & Nephew Reports Change in BlackRock’s Voting Rights
TipRanks · 12/11 17:00
Smith & Nephew Director Invests in Company Shares
TipRanks · 12/09 15:47
Weekly Report: what happened at SNN last week (1202-1206)?
Weekly Report · 12/09 09:04
Smith & Nephew Announces CEO Share Award Vesting
TipRanks · 12/06 12:18
Smith & Nephew Sees Increased Stake by BlackRock
TipRanks · 12/05 16:27
Smith & Nephew Sees Shift in BlackRock’s Holdings
TipRanks · 12/05 11:48
SMITH & NEPHEW <SN.L> : HSBC CUTS TARGET PRICE TO 1160P FROM 1410P
Reuters · 12/04 06:24
BUZZ-JPM sees challenges to continue for European medtech & services in H1
Reuters · 12/03 12:43
Smith & Nephew: Positioned for Growth with Strong Market Performance and Strategic Initiatives
TipRanks · 12/02 12:35
Weekly Report: what happened at SNN last week (1125-1129)?
Weekly Report · 12/02 09:04
More
Webull provides a variety of real-time SNN stock news. You can receive the latest news about Smith & Nephew through multiple platforms. This information may help you make smarter investment decisions.
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.